Sequential Radiotherapy and Chemotherapy in the Treatment of Hodgkin's Disease

Publisher Website
Google Scholar
Abstract
One hundred and two patients with previously untreated Hodgkin's disease, stages IB through IIIB, were randomized within their pathological stage to receive total-lymphoid radiation, either alone or followed by six cycles of MOPP (nitrogen mustard, vincristine, procarbazine, and prednisone) therapy. The group receiving radiotherapy alone had 10 relapses, including 2 deaths from disease. The group assigned to sequential radiotherapy and chemotherapy had one relapse. The number of relapses in the group receiving sequential therapy (1/48) was significantly less than that in the group receiving radiotherapy alone (10/45; P < 0.01). The mean duration of follow-up from the end of MOPP chemotherapy in the 35 patients who completed sequential therapy was 375 days. The MOPP therapy was tolerated by patients who had recently received total-lymphoid radiation, and it significantly improved their probability of disease-free survival (P < 0.01). Actual survival was not significantly different for the two groups (P = 0.10).

This publication has 0 references indexed in Scilit: